Latest Revenue Growth News

Metcash Limited reported an 8.9% rise in FY25 sales revenue to $17.3 billion and an 8.6% increase in underlying EBITDA, driven by strong Food pillar growth and the acquisition of Superior Foods. However, declines in Liquor and Hardware EBIT tempered overall profit growth.

Alcidion Group Limited has upgraded its full-year EBITDA guidance for FY25, now expecting earnings to exceed $4.5 million, driven by contract expansions, cost discipline, and favorable currency effects.

Close the Loop Limited reports a robust cash position exceeding A$30 million and appoints Matthew Zimmer as CEO for North American operations, setting the stage for anticipated revenue and EBITDA growth in FY26.

Motio Ltd has reported a record-breaking Q4 revenue of approximately $2.6 million, marking a 35% year-on-year increase, alongside significant debt reduction and a strong cash position heading into FY26.

Mach7 Technologies has expanded its partnership with a major US radiology marketplace, signing a five-year licence amendment worth A$5 million that extends the contract by three years and adds significant value.

Symal Group is poised to exceed its FY2025 EBITDA forecast, driven by strong project execution and a robust pipeline of contracts and acquisitions.

xReality Group is rapidly transforming its business by focusing on its high-growth Operator XR training platform, while preparing to divest legacy entertainment assets. The company reports record revenue and expanding global reach, particularly in the US defence and law enforcement sectors.

Sprintex Limited has boosted its Türkiye presence by extending its exclusive distribution deal, securing a new A$377,000 order, and launching larger Jet Blowers aimed at industrial and municipal markets.

NEXTDC has locked in a substantial A$2.2 billion senior debt facility, lifting its total borrowing capacity to A$5.1 billion to support expanding data centre operations and recent contract wins.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has secured a significant supply agreement to enter Germany’s burgeoning medical cannabis market, promising at least A$5.6 million in revenue for FY2026.

Audeara Limited has reported record unaudited revenue of $3.64 million for the first 11 months of FY25, marking a 14% increase over FY24 and driven by new product launches and international partnerships.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.